All concerned stakeholders, including Cosmetic Manufacturers, Distributors and Traders, and other related establishments, are invited to participate by registering in the link provided below:
Comment/s and/or position papers are kindly requested to be sent in advance through the same link or via e-mail to [email protected] In the interest of the discussion, participants are also advised to submit their comments and/or position papers on issues pertaining to retention samples, and obtaining a safety assessor.
The virtual consultation will be able to accommodate a maximum of seventy (70) participants and shall be on a first-come, first-served basis. To ensure that all stakeholders are given equal opportunities to attend the public consultation, only one (1) representative per company/industry association shall be allowed to register. Additionally, the FDA will endeavor to provide fair representation for private, civil society, research, and other sectors. Deadline for registration is on 05 September 2022, 12PM.
For any questions or concerns, kindly contact CCHUHSRR at (02) 857-1900 local 8107 or through email at [email protected].